Overview Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss Status: Completed Trial end date: 2016-06-01 Target enrollment: Participant gender: Summary This study aims to demonstrate that the investigational drug AUT00063 is effective and safe in the treatment of age-related hearing loss. Phase: Phase 2 Details Lead Sponsor: Autifony Therapeutics Limited